Expired Study
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials.

Arlington, Texas


Purpose:

This exploratory, 12-month, ascending-dose study will evaluate the safety and effects on visual function of a single injection of Brimonidine intravitreal implant in one eye of patients with Retinitis Pigmentosa.


Criteria:

Inclusion Criteria: - Retinitis Pigmentosa in both eyes - Visual acuity between 20/40 to count fingers Exclusion Criteria: - Growth of new blood vessels in the eye - Any intraocular surgery or laser in either eye in the last 6 months prior to Screening visit or between the Screening visit and Day 1 - Any ocular disease that can interfere with diagnosis and or assessment of disease progression - Significant near-sightedness - HIV - Female patients who are pregnant, nursing, or planning pregnancy


NCT ID:

NCT00661479


Primary Contact:

Study Director
Medical Director
Allergan


Backup Contact:

N/A


Location Contact:

Arlington, Texas
United States



There is no listed contact information for this specific location.

Site Status: N/A


Data Source: ClinicalTrials.gov

Date Processed: January 21, 2018

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.


Click to view Full Listing

This study is not currently recruiting Study Participants on ClinicalConnection.com. The form below is not enabled.